Ok so now I think we can effectively put VIRALEZE approvals in the bottom drawer for now with these new trial results....
Lets focus on what is actually going to get the Share Price moving north. DEP
It has now been several months since the first results of the DEP Ph2 Trials were released and we have not signed one deal......
For the past decade and more the company has told us that the intention was never to take these drugs into Ph3 themselves and that the company would license out these drugs once the proof of concept was confirmed.
Well here we are, proof of concept has seemingly been achieved yet here we sit with no deals in place, little to no incoming revenue and a SP that is close to all time lows.
What is now going on internally at SPL, there is no active trials ongoing, there doesn't seem to be much deals going on, So i have to ask the question...... What does a day in the life of an SPL employee look like?? Pretty cruisy right now it would seem!
Below is some timelines since results have been release from these trials.....
- DEP Iri - 4.5 Months
- DEP Cab - 3.5 Months
- DEP Doc - 1.5 Months
- Forums
- ASX - By Stock
- SPL
- DEP Deals
DEP Deals
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.2¢ |
Change
-0.001(1.08%) |
Mkt cap ! $38.39M |
Open | High | Low | Value | Volume |
9.2¢ | 9.3¢ | 9.1¢ | $210.6K | 2.290M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 467139 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 152000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 467139 | 0.092 |
1 | 22730 | 0.091 |
6 | 98353 | 0.090 |
2 | 80283 | 0.089 |
2 | 45464 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 152000 | 2 |
0.095 | 9947 | 1 |
0.096 | 104177 | 1 |
0.098 | 159206 | 3 |
0.099 | 50000 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |